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SUMMARY 
Background: Wet biofilms associated with medical devices have been widely studied and 
their link with healthcare associated infections (HCAIs) is well recognised. Little attention has 
been paid to the presence of dry biofilms on environmental surfaces in healthcare settings.   
Aim: To investigate the occurrence, prevalence, and diversity of dry biofilms on hospital 
surfaces. 
Method: 61 terminally cleaned items were received from three different UK hospitals. The 
presence of dry biofilm was investigated using culture-based methods and scanning electron 
microscopy (SEM). Bacterial diversity within biofilms was investigated using RISA-PCR and 
next generation sequencing. 
Findings: Multi-species dry biofilms were recovered from 95% of 61 samples. Abundance 
and complexity of dry biofilms were confirmed by SEM. All biofilms harboured Gram-positive 
bacteria including pathogens associated with HCAIs; 58% of samples grew meticillin-
resistant Staphylococcus aureus (MRSA). Dry biofilms had similar physical composition 
regardless of the type of items sampled or the ward from which the samples originated. 
There were differences observed in the dominance of particular species: dry biofilms from 
two hospitals contained mostly staphylococcal DNA, whereas more Bacillus spp. DNA was 
found on surfaces from the third hospital.  
Conclusion: The presence of dry biofilms harbouring bacterial pathogens is virtually 
universal on commonly used items in healthcare settings. The role of dry biofilms in 
spreading HCAIs may be underestimated. The risk may be further exacerbated by inefficient 
cleaning and disinfection practices for hospital surfaces. 
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Introduction 
Healthcare associated infections (HCAIs) affect approximately 20% of National Health 
Service (NHS) patients in the UK, causing significant mortality and financial losses with 
yearly cost for the healthcare systems estimated to be at least $1 billion [1,2]. 
A sizable proportion of HCAIs are preventable through improved practices such as 
environmental hygiene, hand hygiene, use of personal protective equipment, and screening 
and isolation; some estimate this preventable portion to be 20-30% [3,4]. Cleaning is used to 
reduce microbial burden on surfaces, but methods vary widely between hospitals. Most UK 
hospitals use detergents for routine cleaning. Chlorine-based disinfectants are usually 
reserved for terminal or specialised cleaning of areas exposed to antibiotic-resistant bacteria 
and Clostridium difficile, or during high-risk incidents or outbreaks. Efficacy of the cleaning 
process is dependent upon type of equipment, consumables, microbiocidal activity, allotted 
time and motivation of cleaning and/or nursing staff [5,6]. There is evidence that enhanced 
cleaning is cost-effective [7].  
 
Although in studies 98% of patients felt that their hospital room or ward was cleaned 
properly, visual audits used in monitoring the cleanliness of institutions are insufficient [8,9]. 
The best evidence for the role of the environment comes from studies showing the risk of 
infection for patients admitted into a cleaned room recently vacated by a patient with the 
same pathogen [10].  Microbial pathogens can persist on surfaces for days, months and 
even years unless removed by some cleaning or disinfection process [11]. Bacterial biofilms 
are commonly identified on some medical devices and are associated with the presence of 
moisture or/and liquid, for example biofilms on medical devices such as urinary catheters, 
tracheal tubes, breast implants and endoscopes. Around 65% cases of HCAIs are 
associated with “wet” biofilms [12]. However, more recently, biofilm has been discovered on 
dry surfaces, despite effective infection control measures. These biofilms are referred to as 
“dry” biofilms [13,14]. 
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To date, evidence of the presence of dry biofilms on surfaces in healthcare settings remain 
limited. This study aims to provide a better appreciation of the scale, extent, and composition 
of dry biofilms on surfaces that are regularly touched by healthcare workers. 
 
MATERIALS AND METHODS  
Samples 
Samples were collected from different wards and departments from three different hospitals 
in Wales (Hospital A), Scotland (Hospital B) and England (Hospital C), including Trauma & 
Orthopaedics, Adult Intensive Care, Joint Assessment Unit, Acute admission unit, Kidney 
and transplant, Nephrology, Cardiology, Gastroenterology, Intensive therapy unit and 
Haematology (Table I). Items collected included hand sanitising bottles, keyboards, patient 
folders and clipboards. In addition, one hospital provided a commode, a chair and wooden 
tray (part of a food trolley). Due to usage of electronic notes, hospital C was unable to 
provide any patient folders. All samples were kept in sterile bags to avoid cross-
contamination during transportation. Sample processing was carried out under aseptic 
conditions. 
 
Selection of sampling area 
A key was removed from each keyboard and tested separately. The keys selection was 
made based on English letter frequency; letters with similar frequencies were tested (E, T, A 
and O). Folders, clipboards, the chair, commode, sanitising bottles and the trolley were 
sampled from the “high touch” areas. In order to ensure the same surface area was 
investigated for the different materials a 1.5 x 1.5 cm squares were cut from each sample.  
 
Sample rinse and “sterility” testing  
Samples were placed in 50 mL polypropylene conical Falcon™ tubes (Fisher Scientific, 
Loughborough, UK) containing 30 mL of sterilised water and mixed with a Fisherbrand® 
vortex shaker (Fisher Scientific, Loughborough, UK) for 1 minute. After three consecutive 
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rinsing steps, a sterile cotton swab (ThermoFisher Scientific, Newport, UK) was streaked 
over the surface of the sample and incubated at 37°C overnight onto PP0280 TSA plate (EO 
Labs, Bonnybridge, UK). A sample was presumed free from planktonic bacteria if there was 
no bacterial growth observed after rinsing.   
 
Determination of the presence of sessile bacteria  
Following rinsing step, samples were placed into 50 mL polypropylene conical tube 
containing 30 mL of tryptone soya broth (TSB; Oxoid Ltd., Basingstoke, UK) and incubated 
in Sanyo orbital incubator (ThermoFisher Scientific, Newport, UK) at 37°C at 180 RPM. The 
broth was examined for sign of turbidity every 24 hours. 
 
Microbial species determination by genotypic analysis (RISA) 
Ribosomal RNA (rRNA) intergenic spacer analysis (RISA) is a method of microbial 
community analysis to compare samples without culture-dependent bias. Samples were 
prepared as follows: turbid broths were incubated overnight and centrifuged at 1,400 g for 10 
min at 20°C. The supernatant was discarded, and the  pellet was re-suspended with 500 µL of 
TSB. Five hundred µL of 4 M guanidine isothiocyanate (UltraPure™, ThermoFisher Scientific, 
Newport, UK) was added and the suspension was mixed with Wizard™ infrared vortex mixer 
(Firsherbrand™, Fisher Scientific, Loughborough, UK) at 2,000 rpm. One mL of culture mix 
was added into the tubes containing 1 g of 0.1 mm diameter zirconia/silica beads (Thistle 
Scientific, Glasgow, UK) and suspensions were mixed in Bead Bug homogeniser (Benchmark 
Scientific, Cole-Parmer®, St Neots, UK) at 2,800 shaking speed for 2 min.  DNA was amplified 
with Maxwell® 16 Instrument (Promega, Southampton, UK) and quantified by Quibit® 3.0 
fluorometer (ThermoFisher Scientific, Newport, UK). The internal transcribed spacer (ITS) 
bacterial region between the 16S rRNA and 23S rRNA subunit genes was amplified with 
1406F (TGYACACACCGCCCGT, Eurofins Genomics, Ebersberg, Germany) and 23SR 
(GGGTTBCCCCATTCRG, Eurofins Genomics, Ebersberg, Germany) primers by running 
RISA-PCR in thermal cycler (BIO-RAD, Watford, UK) [15]. 
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Microfluidic separation was performed with a 2100 Bioanalyser Instrument (Agilent 
Technologies Ltd, Craven Arms, UK) using DNA 7500 chip (Agilent Technologies Ltd, 
Craven Arms, UK) [16]. 
PCR bands of 55 different hospital samples were cluster-analysed with Bionumerics 
software (Applied Maths, Gent, Belgium) to determine the similarity of RISA-PCR profiles 
between hospitals and wards. Similarity was determined using Pearson coefficient [17]. 
 
Microbial species determination by DNA analysis (next generation sequencing) 
DNA was extracted and quantified as described above. Next generation sequencing (NGS) 
and quality analysis of FASTQ sequence reads was performed by BaseClear Group, 
Netherlands. The 16S rRNA gene (V3-V4) was PCR amplified before sequencing. The 
Illumina MiSeq (PE300) system was used to generate paired-end sequence reads and 
blc2fastq2 2.18 software was utilised to produce FASTQ sequence files. Reads were filtered 
and clipped. Raw sequences were analysed with open source software Edge Bioinformatics 
(v.1.5.1). 
 
Scanning electron microscope (SEM) analysis 
Three randomly selected samples from keyboards, folders, hospital commode and chair 
seating were analysed with SEM to visualise the presence of dry biofilms. Samples were 
prepared by overnight incubation in 2.5% glutaraldehyde solution (Contain™, Fisher 
Scientific, Loughborough, UK) followed by immersion in successive concentrations of 
ethanol for 10 minutes each (10%, 25%, 50%, 70%, 90%, 100%). Prior to SEM scanning, 
samples were coated with 20 nm AuPd coating with sputter coater (SC500, Biorad, UK).  
Secondary electron images were acquired with a beam energy of 5kV using an in-lens 
detector on a Sigma HD Field Emission Gun Scanning Electron Microscope (Carl Zeiss Ltd., 
Cambridge, UK) at 10,000x magnification and 5-7 mm working distance with the help of 
Earth and Ocean Sciences Department, Cardiff University, UK. 
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Statistical analysis 
The strength of linear association between PCR-RISA profiles of dry biofilms recovered from 
hospital samples was calculated using Pearson coefficient with Bionumerics software 
(Applied Maths, Gent, Belgium). Higher linear association between two data sets is 
presented by higher absolute value of Pearson coefficient [17]. The Pearson coefficient 
values were re-calculated into percentage to better reflect the correlation between PCR-
RISA data sets.  
 
RESULTS 
 
Bacterial presence on hospital sample surfaces 
No planktonic bacteria were recovered from any of the 61 samples investigated after multiple 
rinsing steps with sterile water. Bacterial growth in a nutrient rich broth was observed in 95% 
of samples (58/61) (Table I). The assumption was made that bacterial growth resulted from 
the presence of sessile bacteria embedded within the dry surfaces, which was confirmed by 
SEM analysis. Most of the samples (76%) produced growth within 24 hours (Table I). 
 
DNA analysis (RISA-PCR) 
RISA-PCR bands of bacterial cultures recovered from samples were analysed to determine 
the consistency of microbial composition between wards from the same hospital and 
between hospitals (Figure 1). Cluster analysis showed that the majority of bacterial cultures 
share a part of genome, regardless of the sample type or origin. The PCR profiles of hospital 
samples are convergent in 49%, meaning that the similarity between samples is high. 
Similarity of bacterial cultures is consistent within samples originating from hospitals A and B 
with 53% and 45% similarity, but lower for hospital C with 38% similarity.  
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DNA analysis – next generation sequencing (NGS) 
The DNA analysis of the bacterial species recovered from broth cultures following incubation 
of hospital samples was performed by next generation sequencing. NGS allowed more 
precise and detailed analysis of bacterial cultures’ composition than RISA-PCR (Figure 2). 
Bacterial species found from the hospital samples contained mainly staphylococci and 
Bacillus spp. The most common bacteria identified were S. aureus, S. saprophyticus and S. 
epidermidis, with B. licheniformis and B. subtilis being the most common Bacillus spp. The 
only Gram-negative DNA isolated was that of Pseudomonas spp. (Figure 2). 
An average of 18 different bacterial species were present on each surface analysed from the 
dry surface samples.  
Dominance of particular species was associated with their origin (Figure 3). Samples 
isolated from hospitals A and B mostly contained S. aureus and S. epidermidis (34.6% and 
24.6% in hospital A, 23.8% and 24.2% in hospital B, respectively). The most common 
bacteria found from hospital C samples were S. saprophyticus and B. subtilis (20.6% and 
19.1%, respectively).   
Staphylococci generally dominated on hospital A and B surfaces (66% and 53% of dry 
biofilm composition, respectively), whereas in hospital C, Bacillus spp. were dominant (68% 
of dry biofilm composition).  
 
Scanning electron microscope (SEM) analysis 
The previous experiments indicated the presence of multiple sessile bacterial species on the 
surfaces from dry hospital surfaces. SEM was used to visualise the presence and complexity 
of dry biofilms formed on these surfaces. Samples varied in their composition and presence 
of matrix. These dry biofilms formed random clusters of bacterial biofilm on surfaces (Figure 
4).  
 
DISCUSSION 
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A biofilm is a complex community of microorganisms embedded in self-produced 
extracellular polymeric matrix, markedly different from their planktonic state equivalent [18]. 
Most biofilm studies are associated with wet biofilms sessile microorganisms grown in 
aqueous habitats. Little attention has been paid to biofilms grown in dry environments, 
despite their presence on dry hospital surfaces [19]. There is no standardised method for 
biofilm detection on surfaces [12]. Nevertheless, an approach was developed to identify the 
presence of dry biofilm on healthcare surfaces. No viable bacteria were grown following 
rinsing dry surface samples, suggesting that no planktonic bacteria were present. However, 
by immersing the sample surfaces in nutrient broth and following incubation, we were able to 
detect multiple bacterial species from the surfaces, and scattered random microbial biofilm 
were observed by SEM. Indeed, almost all samples (95%) harboured dry biofilms. Similar 
results were obtained by Hu et al, who confirmed the presence of biofilm on 41/44 (93%) 
hospital surface samples [14]. It is conceivable that the rinsing step including vortexing may 
have contributed to dislodging loosely attached bacteria/biofilm [20]. Our results showed, 
however, that the majority of surfaces bear dry biofilms that were not removed or loosen by 
the multiple rinsing steps.  
 
Our study shows staphylococci and Bacillus spp. to be the main bacterial genera recovered 
from the dry biofilms. It was surprising to see some variability between hospitals whereby in 
one study hospital Bacillus spp. were the dominant bacteria. These differences may be 
explained by hospital size, antimicrobial consumption, ventilation and patient infections, 
since patients shed pathogens onto surfaces around them, cleaning and disinfection 
regimens, which will impact on soiling, and possibly differences in the item sampled [21]. 
Here, the three hospitals varied in size: hospitals A and C are 1500 bed teaching hospital in 
wales and in London, whereas hospital B is a Scottish district general hospital with 550 
beds. Detergents are used for routine cleaning in all three hospitals, although in hospital A, 
there is proportionately greater use of chlorine-based disinfectants. All three hospitals 
utilised a terminal cleaning regimen with bleach-type agents for areas exposed to known 
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pathogens such as carbapenemase-producing Enterobacteriaceae (CPE), norovirus, C. 
difficile, MRSA and vancomycin0resistant enterococci (VRE).  We cannot comment on the 
type of patients or their infections as that information was not collected during this study.  
Despite these differences, it was remarkable that dry biofilms on the sampled surfaces were 
widespread and that there was a good similarity of the dry biofilm microbial composition from 
two hospitals. The local environment (urban vs. rural) could also play some parts.  For 
example, external building work has been associated with increased number of bacillus 
spores in healthcare facilities [22,23]. Here, no external building work was reported near or 
within hospital C at the time of sampling, which would have explained the high level of 
Bacillus spp. observed. 
 
S. aureus, S. saprophyticus and S. epidermidis were the dominant Staphylococcus spp.  
MRSA was cultured from a high proportion of samples; the clinical risk associated with this 
finding is yet to be determined. Among Bacillus spp., the prevalent species were B. 
licheniformis and B. subtilis. These results differ from the study by Hu et al, in which no 
Bacillus spp. were reported, although the authors analysed only samples from the critical 
care environment [14]. Nevertheless, it is clear that composition of the isolated biofilms is a 
mixture of environmental, skin and gut microflora, including pathogens. The complexity of 
composition has been reported for biofilm from different surfaces, although overall 
composition depends on the object sampled [14]. Our study showed some variability in the 
detailed composition of the biofilm for the same object between different hospitals. However, 
variability in microbial composition decreased between different objects from the same 
hospital. It is likely that each hospital has its own unique environmentome, which is reflected 
in the composition of biofilm on items and surfaces. 
  
We and others have not addressed the formation of complex dry biofilm on environmental 
surfaces in healthcare settings [13,14].  Bacterial stress such as desiccation and exposure to 
chemicals can enhance the production of extracellular polysaccharides [24-26], which can 
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protect biofilms from adverse chemical and physical effects [27,28]. More of a concern is the 
report of the ineffectiveness of disinfection, notably chlorine-based agents, against dry 
biofilms, and how this impacts on infection control [14,29]. The high prevalence of S. aureus, 
and MRSA in particular, from dry biofilm from the surfaces sampled adds to that concern, 
since MRSA is known to be transmitted through environmental contamination [30]. The 
presence and transmission of pathogens in dry biofilms from healthcare surfaces warrants 
further examination [31,32]. The risk associated with bacterial pathogens recovered in dry 
biofilms with HCAIs is yet to be determined. Some studies link the survival rates of biofilm-
forming strains with persistent nosocomial infections and outbreaks [33,34]. The role of 
Bacillus spp. in protecting bacterial pathogens in biofilm from disinfection also needs to be 
addressed [34-38].  
 
Conclusion 
Our study provides more evidence that complex dry biofilms containing bacterial pathogens 
are virtually universal on hospital surfaces, despite regular cleaning and disinfection. These 
dry biofilms were shown to occur in clusters on different materials and were predominantly 
formed by Gram-positive bacteria although occasional Acinetobacter spp. were identified.  
Unlike other studies, we identified a large proportion of Bacillus spp. The role of Bacillus spp. 
in protecting mixed biofilm community from environmental conditions and disinfection should 
be further investigated [38]. Although these dry biofilms are clearly harboring pathogens, 
their role in transmission needs to be established. This is particularly important in view of the 
failing of disinfection to control these biofilms and the general absence of testing and biocidal 
products claiming efficacy against dry biofilms.  
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Figure 1 Cluster analysis of PCR-RISA bands of cultures recovered from hospital samples 
(keyboards and folders). The scale gives the similarity between a pair of two samples (in a 
range of 0-100%, where 0% indicates no correlation, and 100% indicates complete 
convergence in RISA-PCR profiles). Red dots indicate pairs of the same samples, which are 
not taken into account in analysis. 
 
Figure 2 Percentage of samples containing given species following DNA analysis – all 
samples pooled. 
 
Figure 3 Difference in “dry” biofilm composition between hospitals. Anoxybacillus 
flavithermus: , Bacillus amyloliquefaciens: , Bacillus anthracis: , Bacillus cereus: , 
Bacillus licheniformis: , Bacillus megaterium: , Bacillus pumilus: , Bacillus sp.: , 
Bacillus subtilis: , Bacillus thuringiensis: , Staphylococcus aureus: , Staphylococcus 
epidermidis: , Staphylococcus lugdenensis: , Staphylococcus pasteuri: , 
Staphylococcus saprophyticus: , Staphylococcus warneri: , OTHER: 
 
Figure 4. Examples of “dry” biofilms recovered from surfaces; magnification X10,000. A) and 
B) Patient folders, C) patient chair, D) keyboard key. Images of biofilms were coloured in 
purple to help visualisation and contrast using GNU Image manipulation program (GIMP 2.8) 
software. Images were not otherwise altered. 
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Table I Samples and time for bacterial regrowth in TSB following rinsing 
Hospital A Hospital B Hospital C 
Sample 
number 
Department/
Ward 
Sample type 
Regrowth 
(days)1 
Sample 
number 
Department/
ward 
Sample 
type 
Regrowth 
(days)1 
Sample 
number 
Department/ 
Ward 
Sample 
type 
Regrowth 
(days)1 
1 
Gastroenterology 
folder 1 32 
Microbiology 
patient 
folder 
1 52 
Acute 
admission unit 
keyboard 
no 
regrowth2 
2 
wooden tray 
(food trolley) 
no 
regrowth2 
33 
patient 
folder 
1 53 
Kidney and 
transplant 
keyboard 4 
3 
hospital 
commode 
1 34 
patient 
folder 
1 54 
Cancer 
services and 
haematological 
malignancies 
keyboard 6 
4 
leather chair 
seating 
1 35 
patient 
folder 
1 55 
Kidney and 
transplant 
keyboard 1 
5 
fabric chair 
back support 
1 36 
patient 
folder 
4 56 keyboard 1 
6 
Trauma & 
Orthopaedics 
patient folder 6 37 
patient 
folder 
5 57 
Cardiology 
keyboard 1 
7 patient folder 1 38 
patient 
folder 
1 58 keyboard 7 
8 patient folder 1 39 
Biochemistry 
patient 
folder 
1 59 
Acute 
medicine 
keyboard 1 
9 patient folder 1 40 
patient 
folder 
1 60 
Haematology 
keyboard 1 
10 patient folder 1 41 Pharmacy 
patient 
folder 
1 61 keyboard 
no 
regrowth2 
11 patient folder 2 42 
General 
medicine 
keyboard 1     
12 patient folder 1 43 keyboard 1     
13  patient folder 1 44 keyboard 1     
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14 patient folder 1 45 keyboard 1     
15 patient folder 1 46 keyboard 1     
16 Adult 
Intensive 
Care 
keyboard 1 47 keyboard 1     
17 keyboard 1 48 keyboard 1     
18 keyboard 1 49 keyboard 1     
19 Acute Short 
Stay 
Medicine 
keyboard 2 50 keyboard 1     
20 keyboard 1 51 keyboard 1     
21 keyboard 2         
22 
Gastroenterology 
keyboard 4         
23 keyboard 1         
24 keyboard 4         
25 Nephrology 
 
keyboard 6         
26 keyboard 9         
27 keyboard 1         
28 
Trauma & 
Orthopaedics 
keyboard 7         
29 keyboard 1         
30 
sanitising 
bottle 
1 
        
31 
sanitising 
bottle 
1 
        
 
1
 Time for turbidity to developed following incubation in TSB. 
2
 No regrowth following > 14 days incubation 
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